Sarana Meditama Metropolitan Tbk PT
IDX:SAME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sarana Meditama Metropolitan Tbk PT
IDX:SAME
|
ID |
|
V
|
Vectron Systems AG
F:V3S
|
DE |
|
T
|
TTY Biopharm Co Ltd
TPEX:4105
|
TW |
|
Franklin BSP Realty Trust Inc
F:6VH
|
US |
|
M
|
M31 Technology Corp
TPEX:6643
|
TW |
|
M
|
Muenchener Rueckversicherungs-Gesellschaft in Muenchen AG
XHAN:MUV2
|
DE |
Wall St Price Targets
SAME Price Targets Summary
Sarana Meditama Metropolitan Tbk PT
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SAME's stock price target?
Not Available
SAME does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Sarana Meditama Metropolitan Tbk PT?
Projected CAGR
-12%
Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 9 years is -12%.
What is the Gross Profit forecast for Sarana Meditama Metropolitan Tbk PT?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 10 years is -7%.
What is the Operating Income forecast for Sarana Meditama Metropolitan Tbk PT?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 9 years is -4%.
What is the Pre-Tax Income forecast for Sarana Meditama Metropolitan Tbk PT?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 9 years is -3%.
What is the Net Income forecast for Sarana Meditama Metropolitan Tbk PT?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 9 years is 2%.
